单侧双通道脊柱内镜技术与后路腰椎椎间融合术治疗腰椎退行性疾病患者的疗效比较

doi:10.3969/j.issn.1671-7171.2025.02.029

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1240 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To compare the efficacy of unilateral biportal spinal endoscopic (UBE) and posterior lumbar interbody fusion (PLIF) in the treatment of lumbar degenerative diseases.【Methods】A total of 102 patients with lumbar degenerative diseases treated in our hospital from January 2022 to June 2024 were selected and divided into observation group (n=52, receiving UBE treatment) and control group (n=50, receiving PLIF treatment) according to different surgical methods. Preoperative and postoperative visual analogue scale (VAS) score, Japanese Orthopaedic Society (JOA) score, C-reactive protein (CRP) level and erythrocyte precipitation rate (ESR) were compared between the two groups.【Results】The intraoperative blood loss and postoperative drainage volume of the observation group were less than those of the control group, and the hospitalization time was shorter than that of the control group (P<0.05). 7 days after surgery, VAS score of the observation group was lower than that of the control group, JOA score was higher than that of the control group (P<0.05). The levels of CRP and ESR in the observation group were lower than those in the control group (P<0.05). There was no significant difference in the total incidence of complications between the two groups (P>0.05).【Conclusion】Compared with traditional PLIF therapy, UBE has less blood loss, shorter hospital stay, and more significant pain relief effect in the treatment of lumbar degenerative diseases. Moreover, the complication rates of the two surgical methods are similar, suggesting that UBE is a safe and effective treatment.

Key words： Spinal Diseases Spinal Fusion Endoscopy Treatment Outcome

Received: 30 December 2024

PACS:

R681.5

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2025.02.029 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2025/V42/I2/275

[1] 周浩盛,柳栋元,刘晓亮,等. 足下垂型腰椎退行性疾病研究进展[J].国际骨科学杂志,2024,45(3):199-202.
[2] 宋跃明,丰干钧. 腰椎退行性疾病外科治疗的发展与趋势[J].西部医学,2024,36(8):1093-1096.
[3] 于同,矫健航,吴敏飞. 单侧双通道内镜技术治疗腰椎退行性疾病的手术并发症的研究进展[J].中华医学杂志,2023,103(3):224-228.
[4] 李熹,刘磊,张哲,等. 责任节段上位固定椎与邻近上位椎体不稳的腰椎退行性疾病的手术策略[J].中华骨科杂志,2024,44(10):658-668.
[5] 孙林,李晓枫,黄泽玉,等. 大通道下脊柱内镜经后路腰椎椎间融合术治疗腰椎退行性疾病的研究进展[J].国际外科学杂志,2024,51(7):499-504.
[6] 官丙刚,杨强. 单侧双通道脊柱内镜治疗腰椎退行性疾病的进展[J].中国矫形外科杂志,2024,32(13):1210-1214.
[7] 倪博然,赵进喜,黄为钧,等. 基于视觉模拟评分法探究中医临床疗效评价新方法[J].中华中医药杂志,2021,36(1):288-292.
[8] 李旭,秦东京,曹新山,等. 无骨折脱位型颈脊髓损伤DTI征象与JOA评分的相关性[J].山东大学学报(医学版),2013,51(1):83-87.
[9] 王辉,王开众,李忠海. 椎旁肌与腰椎退行性疾病关系的研究进展[J].中国脊柱脊髓杂志,2024,34(8):880-884.
[10] 刘界,王国华. SWE技术定量评估椎旁肌在腰椎退行性疾病中的应用进展[J].医学临床研究,2023,40(5):644-647.
[11] 罗辑,余璐鑫,郭金伟. 腰椎退行性疾病患者行后路腰椎融合手术的疗效影响因素[J].颈腰痛杂志,2021,42(5):664-667.
[12] 栗磊,苏振炎,张益宏,等. 腰椎退行性疾病行后路减压椎间融合术后切口深部感染的病原学、治疗及风险因素分析[J].颈腰痛杂志,2023,44(6):966-970.
[13] 曾伟,赵郭盛,林路,等. 一期后路保留椎板病灶清除治疗单节段胸腰椎结核的短期疗效分析[J].重庆医学,2024,53(4):508.